Spyre Therapeutics Inc
NASDAQ:SYRE

Watchlist Manager
Spyre Therapeutics Inc Logo
Spyre Therapeutics Inc
NASDAQ:SYRE
Watchlist
Price: 33.4 USD -0.21% Market Closed
Market Cap: 2.6B USD

Intrinsic Value

The intrinsic value of one SYRE stock under the Base Case scenario is hidden USD. Compared to the current market price of 33.4 USD, Spyre Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

SYRE Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Spyre Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

SYRE looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether SYRE usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about SYRE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SYRE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Spyre Therapeutics Inc.

Explain Valuation
Compare SYRE to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SYRE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Spyre Therapeutics Inc

Current Assets 608.5m
Cash & Short-Term Investments 603.1m
Other Current Assets 5.4m
Non-Current Assets 10k
Other Non-Current Assets 10k
Current Liabilities 54.1m
Accounts Payable 1.3m
Accrued Liabilities 27.7m
Other Current Liabilities 25.1m
Non-Current Liabilities 36.6m
Other Non-Current Liabilities 36.6m
Efficiency

Free Cash Flow Analysis
Spyre Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Spyre Therapeutics Inc

Revenue
0 USD
Operating Expenses
-208.6m USD
Operating Income
-208.6m USD
Other Expenses
548k USD
Net Income
-208m USD
Fundamental Scores

SYRE Profitability Score
Profitability Due Diligence

Spyre Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Spyre Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

SYRE Solvency Score
Solvency Due Diligence

Spyre Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Spyre Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SYRE Price Targets Summary
Spyre Therapeutics Inc

Wall Street analysts forecast SYRE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYRE is 53.13 USD with a low forecast of 21.21 USD and a high forecast of 73.5 USD.

Lowest
Price Target
21.21 USD
36% Downside
Average
Price Target
53.13 USD
59% Upside
Highest
Price Target
73.5 USD
120% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Spyre Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SYRE is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SYRE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SYRE stock?

The intrinsic value of one SYRE stock under the Base Case scenario is hidden USD.

Is SYRE stock undervalued or overvalued?

Compared to the current market price of 33.4 USD, Spyre Therapeutics Inc is hidden .

Back to Top